Plain-English translation of NCT03460769 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Pancreatic Cancer research guide →This trial is evaluating a mixed meal test — where you eat a standardized meal and have blood drawn at specific times afterward — to help doctors better diagnose and characterize a type of diabetes that develops as a result of pancreatic cancer or chronic pancreatitis. Researchers want to understand how the pancreas responds to food in people with these conditions, compared to people with type 2 diabetes or no diabetes at all. The goal is to develop a better way to identify this specific type of diabetes early and understand what's happening in the pancreas.
When the pancreas is damaged by cancer or chronic inflammation, it can develop a special type of diabetes that is often missed or confused with type 2 diabetes. There is currently no reliable test to quickly spot this diabetes in patients with pancreatic disease. This study aims to create a simple, standardized test that doctors can use to identify and better understand this type of diabetes so patients can receive more targeted treatment.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will visit the research center at MD Anderson Cancer Center where you will eat a standardized meal and have blood samples taken at several time points before and after eating. For some participants, only fasting blood samples (collected before eating) may be required. The research team will measure how your body responds to the meal by checking levels of insulin, glucose, and other pancreatic hormones in your blood. The study team will coordinate all visits and manage the data collected from all participants.
AI-generated summary from trial data · Jul 21, 2026 · Not medical advice
United States